HomeInsights52 Week High Stocks

Emcure Pharmaceuticals Ltd 52 Week High

Emcure Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

4.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

YEARHIGH

₹ 1577.5

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Emcure Pharmaceuticals Ltd is ₹ 1577 as of 22 Nov 24 .

Company Fundamentals for Emcure Pharmaceuticals Ltd

No data available

Market Price of Emcure Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241313.6
21 Nov 20241284.2
19 Nov 20241306.05
18 Nov 20241310.5
14 Nov 20241358.75
13 Nov 20241333.85
12 Nov 20241399.15
11 Nov 20241432.65
08 Nov 20241396.85
07 Nov 20241437.35

Asset Value vs Market Value of Emcure Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Emcure Pharmaceuticals Ltd News Hub

News

Emcure Pharmaceuticals allots 3.33 lakh equity shares under ESOS

Emcure Pharmaceuticals has allotted 3,33,500 equity shares under ESOS on 22 November 2024....

Read more

22 Nov 202417:56

News

Emcure Pharma Q2 PAT rises 38.2% YoY

In Q2FY25, the drug maker's consolidated revenue from operations stood at Rs 2,002 crore, ...

Read more

08 Nov 202412:50

News

Emcure Pharmaceuticals to hold board meeting

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...

Read more

02 Nov 202413:58

News

Emcure Pharmaceuticals to announce Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...

Read more

31 Oct 202410:43

News

Emcure signs licensing agreement with Gilead Sciences

Emcure Pharmaceuticals announced the signing of a royalty-free voluntary licensing agreeme...

Read more

03 Oct 202410:15

News

Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities

Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigne...

Read more

13 Aug 202419:01

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Emcure Pharmaceuticals Ltd

What is the significance of Emcure Pharmaceuticals Ltd reaching its 52-week high?

Emcure Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Emcure Pharmaceuticals Ltd 52-week high?

Investors monitor Emcure Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Emcure Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Emcure Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Emcure Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Emcure Pharmaceuticals Ltd at its 52-week high?

Before investing in Emcure Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Emcure Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Emcure Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*